772 related articles for article (PubMed ID: 18547522)
1. A specific cholesterol binding site is established by the 2.8 A structure of the human beta2-adrenergic receptor.
Hanson MA; Cherezov V; Griffith MT; Roth CB; Jaakola VP; Chien EY; Velasquez J; Kuhn P; Stevens RC
Structure; 2008 Jun; 16(6):897-905. PubMed ID: 18547522
[TBL] [Abstract][Full Text] [Related]
2. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor.
Cherezov V; Rosenbaum DM; Hanson MA; Rasmussen SG; Thian FS; Kobilka TS; Choi HJ; Kuhn P; Weis WI; Kobilka BK; Stevens RC
Science; 2007 Nov; 318(5854):1258-65. PubMed ID: 17962520
[TBL] [Abstract][Full Text] [Related]
3. Cholesterol modulates the dimer interface of the β₂-adrenergic receptor via cholesterol occupancy sites.
Prasanna X; Chattopadhyay A; Sengupta D
Biophys J; 2014 Mar; 106(6):1290-300. PubMed ID: 24655504
[TBL] [Abstract][Full Text] [Related]
4. The Principles of Ligand Specificity on beta-2-adrenergic receptor.
Chan HC; Filipek S; Yuan S
Sci Rep; 2016 Oct; 6():34736. PubMed ID: 27703221
[TBL] [Abstract][Full Text] [Related]
5. Cholesterol-β1 AR interaction versus cholesterol-β2 AR interaction.
Cang X; Yang L; Yang J; Luo C; Zheng M; Yu K; Yang H; Jiang H
Proteins; 2014 May; 82(5):760-70. PubMed ID: 24265091
[TBL] [Abstract][Full Text] [Related]
6. Molecular dynamics simulations of the effect of the G-protein and diffusible ligands on the β2-adrenergic receptor.
Goetz A; Lanig H; Gmeiner P; Clark T
J Mol Biol; 2011 Dec; 414(4):611-23. PubMed ID: 22037586
[TBL] [Abstract][Full Text] [Related]
7. Identifying conformational changes of the beta(2) adrenoceptor that enable accurate prediction of ligand/receptor interactions and screening for GPCR modulators.
Reynolds KA; Katritch V; Abagyan R
J Comput Aided Mol Des; 2009 May; 23(5):273-88. PubMed ID: 19148767
[TBL] [Abstract][Full Text] [Related]
8. Structure-Based Prediction of G-Protein-Coupled Receptor Ligand Function: A β-Adrenoceptor Case Study.
Kooistra AJ; Leurs R; de Esch IJ; de Graaf C
J Chem Inf Model; 2015 May; 55(5):1045-61. PubMed ID: 25848966
[TBL] [Abstract][Full Text] [Related]
9. GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function.
Rosenbaum DM; Cherezov V; Hanson MA; Rasmussen SG; Thian FS; Kobilka TS; Choi HJ; Yao XJ; Weis WI; Stevens RC; Kobilka BK
Science; 2007 Nov; 318(5854):1266-73. PubMed ID: 17962519
[TBL] [Abstract][Full Text] [Related]
10. Modes of Cholesterol Binding in Membrane Proteins: A Joint Analysis of 73 Crystal Structures.
Wang C; Ralko A; Ren Z; Rosenhouse-Dantsker A; Yang X
Adv Exp Med Biol; 2019; 1135():67-86. PubMed ID: 31098811
[TBL] [Abstract][Full Text] [Related]
11. Mapping the functional binding sites of cholesterol in β2-adrenergic receptor by long-time molecular dynamics simulations.
Cang X; Du Y; Mao Y; Wang Y; Yang H; Jiang H
J Phys Chem B; 2013 Jan; 117(4):1085-94. PubMed ID: 23298417
[TBL] [Abstract][Full Text] [Related]
12. Structural basis for ligand binding and specificity in adrenergic receptors: implications for GPCR-targeted drug discovery.
Huber T; Menon S; Sakmar TP
Biochemistry; 2008 Oct; 47(42):11013-23. PubMed ID: 18821775
[TBL] [Abstract][Full Text] [Related]
13. Two classes of cholesterol binding sites for the β2AR revealed by thermostability and NMR.
Gater DL; Saurel O; Iordanov I; Liu W; Cherezov V; Milon A
Biophys J; 2014 Nov; 107(10):2305-12. PubMed ID: 25418299
[TBL] [Abstract][Full Text] [Related]
14. Use of the X-ray structure of the Beta2-adrenergic receptor for drug discovery.
Topiol S; Sabio M
Bioorg Med Chem Lett; 2008 Mar; 18(5):1598-602. PubMed ID: 18243704
[TBL] [Abstract][Full Text] [Related]
15. Use of the X-ray structure of the beta2-adrenergic receptor for drug discovery. Part 2: Identification of active compounds.
Sabio M; Jones K; Topiol S
Bioorg Med Chem Lett; 2008 Oct; 18(20):5391-5. PubMed ID: 18829308
[TBL] [Abstract][Full Text] [Related]
16. Lipid-mediated dimerization of beta2-adrenergic receptor reveals important clues for cannabinoid receptors.
Dainese E; Oddi S; Maccarrone M
Cell Mol Life Sci; 2008 Aug; 65(15):2277-9. PubMed ID: 18500446
[TBL] [Abstract][Full Text] [Related]
17. The role of cholesterol on the activity and stability of neurotensin receptor 1.
Oates J; Faust B; Attrill H; Harding P; Orwick M; Watts A
Biochim Biophys Acta; 2012 Sep; 1818(9):2228-33. PubMed ID: 22551944
[TBL] [Abstract][Full Text] [Related]
18. An insilico approach to high altitude pulmonary edema - Molecular modeling of human beta2 adrenergic receptor and its interaction with Salmeterol & Nifedipine.
Chandramoorthi GD; Piramanayagam S; Marimuthu P
J Mol Model; 2008 Sep; 14(9):849-56. PubMed ID: 18512086
[TBL] [Abstract][Full Text] [Related]
19. Influence of lipid composition on the structural stability of g-protein coupled receptor.
Mahmood I; Liu X; Neya S; Hoshino T
Chem Pharm Bull (Tokyo); 2013; 61(4):426-37. PubMed ID: 23546002
[TBL] [Abstract][Full Text] [Related]
20. Molecular modeling of A1 and A2A adenosine receptors: comparison of rhodopsin- and beta2-adrenergic-based homology models through the docking studies.
Yuzlenko O; Kieć-Kononowicz K
J Comput Chem; 2009 Jan; 30(1):14-32. PubMed ID: 18496794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
